
Chr. Hansen lends its microbiome knowhow in Lonza biotherapeutics deal
Chr. Hansen applies its microbiome expertise in the pharma arena as the firm enters a collaboration with Lonza to produce live biotherapeutic (LBP) products that address a range of gastrointestinal and cardiovascular conditions.